Chemomab Therapeutics Ltd.(CMMB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CMMB Chemomab Therapeutics Ltd.

盘后交易 12-20 18:13:42 EST

1.68

+0.06

+3.70%

盘后1.63

-0.05-2.98%

17:27 EST

最高1.68	最低1.61	成交量4.02万
今开1.62	昨收1.62	日振幅4.49%
总市值3,168万	流通市值2,180万	总股本1,886万
成交额6.57万	换手率0.31%	流通股本1,297万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CMMB","market":"US","secType":"STK","nameCN":"Chemomab Therapeutics Ltd.","latestPrice":1.68,"timestamp":1734728392583,"preClose":1.62,"halted":0,"volume":40225,"hourTrading":{"tag":"盘后","latestPrice":1.63,"preClose":1.68,"latestTime":"17:27 EST","volume":1369,"amount":2245.1100315,"timestamp":1734733646228},"delay":0,"floatShares":12973900,"shares":18856611,"eps":-0.974934,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.06,"latestTime":"12-20 18:13:42 EST","open":1.62,"high":1.68,"low":1.6073,"amount":65691.2664875,"amplitude":0.044877,"askPrice":1.75,"askSize":81,"bidPrice":1.63,"bidSize":1134,"shortable":3,"etf":0,"ttmEps":-0.974934,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1734742800000},"adr":0,"listingDate":1549947600000,"adjPreClose":1.62,"adrRate":20,"preHourTrading":{"tag":"盘前","latestPrice":1.6105,"preClose":1.62,"latestTime":"08:00 EST","volume":1,"amount":1.6105,"timestamp":1734699601705},"postHourTrading":{"tag":"盘后","latestPrice":1.63,"preClose":1.68,"latestTime":"17:27 EST","volume":1369,"amount":2245.1100315,"timestamp":1734733646228},"volumeRatio":0.39136},"requestUrl":"/m/hq/s/CMMB/tweets","defaultTab":"tweets","newsList":[{"id":"2492153237","title":"Chemomab Therapeutics Ltd盘中异动 急速下跌5.31%报1.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492153237","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492153237?lang=zh_cn&edition=full","pubTime":"2024-12-19 03:56","pubTimestamp":1734551784,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日03时56分，Chemomab Therapeutics Ltd股票出现波动，股价大幅下跌5.31%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体跌幅为1.93%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。CM-101已经显示出有潜力治疗多种严重和危及生命的纤维化和炎症性疾病。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219035624ab828ca1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219035624ab828ca1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CMMB"],"gpt_icon":0},{"id":"2491134856","title":"Chemomab Therapeutics Ltd盘中异动 股价大涨7.23%报1.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491134856","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491134856?lang=zh_cn&edition=full","pubTime":"2024-12-16 23:36","pubTimestamp":1734363362,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日23时36分，Chemomab Therapeutics Ltd股票出现波动，股价急速上涨7.23%。截至发稿，该股报1.69美元/股，成交量3.2816万股，换手率0.17%，振幅2.53%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体涨幅为0.62%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216233602a1f3617b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216233602a1f3617b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CMMB"],"gpt_icon":0},{"id":"2491030518","title":"Chemomab Therapeutics Ltd盘中异动 临近午盘急速跳水6.23%报1.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491030518","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491030518?lang=zh_cn&edition=full","pubTime":"2024-12-14 00:58","pubTimestamp":1734109128,"startTime":"0","endTime":"0","summary":"北京时间2024年12月14日00时58分，Chemomab Therapeutics Ltd股票出现波动，股价急速下跌6.23%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体跌幅为0.49%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。CM-101已经显示出有潜力治疗多种严重和危及生命的纤维化和炎症性疾病。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214005848a1ec754c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214005848a1ec754c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CMMB","LENZ"],"gpt_icon":0},{"id":"2490010122","title":"Chemomab Therapeutics Ltd盘中异动 快速拉升5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490010122","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490010122?lang=zh_cn&edition=full","pubTime":"2024-12-11 00:07","pubTimestamp":1733846860,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日00时07分，Chemomab Therapeutics Ltd股票出现波动，股价大幅上涨5.33%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体跌幅为1.08%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。CM-101已经显示出有潜力治疗多种严重和危及生命的纤维化和炎症性疾病。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211000740a1e3c313&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211000740a1e3c313&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CMMB","LENZ"],"gpt_icon":0},{"id":"2488319082","title":"Chemomab Therapeutics Ltd盘中异动 股价大跌5.78%报1.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488319082","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488319082?lang=zh_cn&edition=full","pubTime":"2024-12-04 22:59","pubTimestamp":1733324377,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日22时59分，Chemomab Therapeutics Ltd股票出现异动，股价大幅下跌5.78%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体涨幅为0.06%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204225937abf5d642&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204225937abf5d642&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CMMB","BK4139"],"gpt_icon":0},{"id":"2488894574","title":"Chemomab Therapeutics Ltd盘中异动 早盘快速上涨6.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488894574","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488894574?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:31","pubTimestamp":1733236273,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时31分，Chemomab Therapeutics Ltd股票出现异动，股价急速拉升6.70%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体跌幅为0.25%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。CM-101已经显示出有潜力治疗多种严重和危及生命的纤维化和炎症性疾病。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223113a26994de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223113a26994de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CMMB","BK4139","LENZ"],"gpt_icon":0},{"id":"2485744211","title":"Chemomab Therapeutics Ltd盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485744211","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485744211?lang=zh_cn&edition=full","pubTime":"2024-11-23 04:54","pubTimestamp":1732308877,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日04时54分，Chemomab Therapeutics Ltd股票出现异动，股价快速上涨5.00%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体涨幅为0.43%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。CM-101已经显示出有潜力治疗多种严重和危及生命的纤维化和炎症性疾病。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123045437abd82929&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123045437abd82929&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CMMB","BK4139","LENZ"],"gpt_icon":0},{"id":"2485135298","title":"Chemomab Therapeutics Ltd2024财年第三财季实现净利润-3.49百万美元，同比增加14.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485135298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485135298?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:02","pubTimestamp":1732291347,"startTime":"0","endTime":"0","summary":"11月23日，Chemomab Therapeutics Ltd公布财报，公告显示公司2024财年第三财季净利润为-3.49百万美元，同比增加14.25%；其中营业收入为0.00美元，每股基本收益为-0.20美元。从资产负债表来看，Chemomab Therapeutics Ltd总负债4.58百万美元，其中短期债务112000.46美元，资产负债比为4.57，流动比率为4.58。机构评级：截至2024年11月23日，当前有3家机构对Chemomab Therapeutics Ltd目标价做出预测，其中目标均价为8.00美元，其中最低目标价为4.00美元，最高目标价为11.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000256abd7b90a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000256abd7b90a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CMMB","LENZ"],"gpt_icon":0},{"id":"2485335419","title":"Chemomab Therapeutics Ltd盘中异动 急速跳水5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485335419","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485335419?lang=zh_cn&edition=full","pubTime":"2024-11-21 23:44","pubTimestamp":1732203868,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日23时44分，Chemomab Therapeutics Ltd股票出现异动，股价急速下跌5.18%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体跌幅为0.19%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112123442898e43f58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112123442898e43f58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CMMB"],"gpt_icon":0},{"id":"2484797608","title":"Chemomab Therapeutics Ltd盘中异动 股价大跌6.06%报1.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484797608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484797608?lang=zh_cn&edition=full","pubTime":"2024-11-20 02:19","pubTimestamp":1732040383,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日02时19分，Chemomab Therapeutics Ltd股票出现波动，股价大幅下挫6.06%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体跌幅为1.45%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。CM-101已经显示出有潜力治疗多种严重和危及生命的纤维化和炎症性疾病。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120021943971a77f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120021943971a77f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CMMB"],"gpt_icon":0},{"id":"2484600305","title":"Chemomab Therapeutics Ltd盘中异动 下午盘股价大跌5.07%报1.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484600305","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484600305?lang=zh_cn&edition=full","pubTime":"2024-11-19 03:16","pubTimestamp":1731957392,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日03时16分，Chemomab Therapeutics Ltd股票出现异动，股价急速下跌5.07%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体跌幅为0.01%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。CM-101已经显示出有潜力治疗多种严重和危及生命的纤维化和炎症性疾病。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111903163298e43544&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111903163298e43544&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CMMB","BK4139","LENZ"],"gpt_icon":0},{"id":"2483006338","title":"Chemomab Therapeutics Ltd盘中异动 早盘股价大跌5.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483006338","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483006338?lang=zh_cn&edition=full","pubTime":"2024-11-14 23:25","pubTimestamp":1731597919,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日23时25分，Chemomab Therapeutics Ltd股票出现波动，股价急速下跌5.75%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体跌幅为0.79%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114232520a237ef5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114232520a237ef5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CMMB","BK4139","LENZ"],"gpt_icon":0},{"id":"2483882144","title":"Chemomab Therapeutics Ltd盘中异动 早盘快速跳水6.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483882144","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483882144?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:56","pubTimestamp":1731509799,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时56分，Chemomab Therapeutics Ltd股票出现波动，股价急速下挫6.22%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体涨幅为0.31%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113225640971a64e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113225640971a64e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CMMB","BK4139","LENZ"],"gpt_icon":0},{"id":"2482089464","title":"Chemomab Therapeutics Ltd盘中异动 早盘快速上涨5.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482089464","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482089464?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:51","pubTimestamp":1731423097,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日22时51分，Chemomab Therapeutics Ltd股票出现波动，股价大幅上涨5.68%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体跌幅为0.13%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112225138971a6070&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112225138971a6070&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CMMB","LENZ"],"gpt_icon":0},{"id":"2482304738","title":"Chemomab Therapeutics Ltd盘中异动 早盘股价大涨6.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482304738","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482304738?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:31","pubTimestamp":1731335508,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时31分，Chemomab Therapeutics Ltd股票出现波动，股价快速上涨6.12%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体跌幅为0.05%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。CM-101已经显示出有潜力治疗多种严重和危及生命的纤维化和炎症性疾病。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223148971a5adb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223148971a5adb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CMMB","LENZ"],"gpt_icon":0},{"id":"2479095455","title":"Chemomab Therapeutics Ltd盘中异动 下午盘股价大涨5.21%报1.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479095455","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479095455?lang=zh_cn&edition=full","pubTime":"2024-10-29 03:03","pubTimestamp":1730142201,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日03时03分，Chemomab Therapeutics Ltd股票出现波动，股价急速上涨5.21%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体涨幅为0.07%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。CM-101已经显示出有潜力治疗多种严重和危及生命的纤维化和炎症性疾病。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029030321a1f2dd97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029030321a1f2dd97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CMMB"],"gpt_icon":0},{"id":"2478965768","title":"Chemomab Therapeutics Ltd盘中异动 股价大跌5.16%报1.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478965768","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478965768?lang=zh_cn&edition=full","pubTime":"2024-10-25 00:38","pubTimestamp":1729787907,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日00时38分，Chemomab Therapeutics Ltd股票出现波动，股价大幅下跌5.16%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体涨幅为0.21%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。CM-101已经显示出有潜力治疗多种严重和危及生命的纤维化和炎症性疾病。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102500382798e3e4c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102500382798e3e4c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CMMB"],"gpt_icon":0},{"id":"2477530520","title":"Chemomab Therapeutics Ltd盘中异动 急速跳水5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477530520","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477530520?lang=zh_cn&edition=full","pubTime":"2024-10-23 23:40","pubTimestamp":1729698030,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日23时40分，Chemomab Therapeutics Ltd股票出现波动，股价大幅跳水5.06%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体跌幅为1.48%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。CM-101已经显示出有潜力治疗多种严重和危及生命的纤维化和炎症性疾病。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102323403198e3e088&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102323403198e3e088&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CMMB","BK4139","LENZ"],"gpt_icon":0},{"id":"2477353841","title":"Chemomab Therapeutics Ltd盘中异动 急速上涨6.13%报1.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477353841","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477353841?lang=zh_cn&edition=full","pubTime":"2024-10-22 22:13","pubTimestamp":1729606421,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日22时13分，Chemomab Therapeutics Ltd股票出现异动，股价急速上涨6.13%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体跌幅为0.77%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。CM-101已经显示出有潜力治疗多种严重和危及生命的纤维化和炎症性疾病。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022221342971a19f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022221342971a19f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CMMB","BK4139"],"gpt_icon":0},{"id":"2476026694","title":"Chemomab Therapeutics Ltd盘中异动 股价大涨12.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476026694","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476026694?lang=zh_cn&edition=full","pubTime":"2024-10-18 23:51","pubTimestamp":1729266661,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日23时51分，Chemomab Therapeutics Ltd股票出现波动，股价大幅拉升12.50%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体涨幅为0.20%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。CM-101已经显示出有潜力治疗多种严重和危及生命的纤维化和炎症性疾病。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018235101ab6b3386&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018235101ab6b3386&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CMMB","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chemomab.com","stockEarnings":[{"period":"1week","weight":-0.0414},{"period":"1month","weight":0},{"period":"3month","weight":-0.0526},{"period":"6month","weight":0.7419},{"period":"1year","weight":2.1827},{"period":"ytd","weight":2.1765}],"compareEarnings":[{"period":"1week","weight":-0.0302},{"period":"1month","weight":-0.0071},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.0764},{"period":"1year","weight":0.2517},{"period":"ytd","weight":0.2331}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Chemomab Therapeutics Ltd.于2011年9月22日根据以色列公司法在以色列注册成立。Chemomab是一家处于临床阶段的生物技术公司，致力于发现和开发针对高度未满足需求的纤维化相关疾病的创新疗法。 基于可溶性蛋白CCL24在促进纤维化和炎症中的独特和关键作用，Chemomab开发了CM-101，这是一种旨在结合和阻断CCL24活性的单克隆抗体。 CM-101具有治疗多种严重且威胁生命的炎性和纤维化疾病的潜力，目前正针对孤儿疾病，原发性硬化性胆管炎（PSC）和系统性硬化症（SSc）进行临床开发。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.064627},{"month":2,"riseRate":0.4,"avgChangeRate":0.038789},{"month":3,"riseRate":0.5,"avgChangeRate":-0.085415},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.080718},{"month":5,"riseRate":0.5,"avgChangeRate":0.041337},{"month":6,"riseRate":0.5,"avgChangeRate":0.017965},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.112804},{"month":8,"riseRate":0.5,"avgChangeRate":0.065779},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.13437},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.069486},{"month":11,"riseRate":0.5,"avgChangeRate":-0.035016},{"month":12,"riseRate":0.333333,"avgChangeRate":0.034658}],"exchange":"NASDAQ","name":"Chemomab Therapeutics Ltd.","nameEN":"Chemomab Therapeutics Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Chemomab Therapeutics Ltd.(CMMB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Chemomab Therapeutics Ltd.(CMMB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Chemomab Therapeutics Ltd.,CMMB,Chemomab Therapeutics Ltd.股票,Chemomab Therapeutics Ltd.股票老虎,Chemomab Therapeutics Ltd.股票老虎国际,Chemomab Therapeutics Ltd.行情,Chemomab Therapeutics Ltd.股票行情,Chemomab Therapeutics Ltd.股价,Chemomab Therapeutics Ltd.股市,Chemomab Therapeutics Ltd.股票价格,Chemomab Therapeutics Ltd.股票交易,Chemomab Therapeutics Ltd.股票购买,Chemomab Therapeutics Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Chemomab Therapeutics Ltd.(CMMB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Chemomab Therapeutics Ltd.(CMMB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}